Musculoskeletal Disorders
From the Journals
Stopping JIA drugs? Many can regain control after a flare
About 67% of patients who stopped medications for well-controlled JIA got their condition under control by 1 year after postflare treatment,...
News from the FDA/CDC
Ustekinumab becomes second biologic approved for PsA in kids
The approval is based on an extrapolation of data from adult trials in active psoriatic arthritis and adult and pediatric studies in moderate to...
From the Journals
Uveitis in juvenile arthritis patients persists into midlife
Data suggest the need for lifelong ophthalmic checkups for JIA patients diagnosed with uveitis.
Feature
No more ‘escape hatch’: Post Roe, new worries about meds linked to birth defects
Physicians fear that women won’t get the best treatments or will face dangerous risks.
Conference Coverage
Biomarkers may help to predict persistent oligoarticular JIA
Analysis of a small group of samples revealed that the selected biomarkers more accurately predicted persistent disease than disease likely to...
News
FDA expands indication for spinal muscular atrophy drug
After 12 months of risdiplam treatment, the majority of presymptomatic infants with SMA reached key motor milestones.
Conference Coverage
Pfizer COVID vaccine performs well in youth with rheumatic diseases
Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.
Guidelines
Myositis guidelines aim to standardize adult and pediatric care
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
Conference Coverage
Prior authorizations delay TNF inhibitors for children with JIA
Many patients newly diagnosed with juvenile idiopathic arthritis (JIA) at one academic center over a year had delays in care due to unnecessary...
From the Journals
Children with RMDs not at high risk for severe COVID-19, study finds
“Many parents and families with children who have RMDs have lived with great fear over the pandemic about whether or not their children are at an...
From the Journals
JIA disease activity, disability linked to social factors
For patients with polyarticular juvenile idiopathic arthritis, levels of disease activity and disability vary, depending on family income,...